| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.037 | 0.4 |